Medicare’s new Part D program is aiming to cover certain GLP-1 medications for people with obesity, potentially lowering costs for eligible patients (with a co-pay mentioned around $50/month). In this episode, Liz Seegert, Health & Aging Journalist, breaks down what’s actually changing—and why access isn’t as simple as “yes, GLP-1s are covered.”